{{Rsnum
|rsid=4710654
|Chromosome=6
|position=67471804
|Orientation=plus
|GMAF=0.3765
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 20.8 | 34.0 | 45.3
| HCB | 2.9 | 27.9 | 69.1
| JPT | 0.9 | 31.2 | 67.9
| YRI | 40.7 | 37.0 | 22.2
| ASW | 21.4 | 58.9 | 19.6
| CHB | 2.9 | 27.9 | 69.1
| CHD | 1.9 | 31.1 | 67.0
| GIH | 14.3 | 50.0 | 35.7
| LWK | 23.8 | 65.7 | 10.5
| MEX | 8.9 | 44.6 | 46.4
| MKK | 22.8 | 49.7 | 27.5
| TSI | 11.2 | 46.9 | 41.8
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=22952603
  |Trait=Response to amphetamines
  |Title=Genome-wide association study of d-amphetamine response in healthy volunteers identifies putative associations, including cadherin 13 (CDH13).
  |RiskAllele=
  |Pval=8E-7
  |OR=NR
  |ORtxt=NR
  |OA=1
}}

{{on chip | Illumina Human 1M}}